Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,385,402
+$2,178,602 QoQ
Shares Held
35,418
+975.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#362
of 966 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $654,461,135 across 13 Medical Devices names. DXCM ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,512,160 | $230,226,360 | |
| 2 | NEOG |
Neogen Corp
|
9,333,261 | $83,906,016 | |
| 3 | HAE |
Haemonetics Corp
|
1,101,371 | $82,602,825 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
3,265,704 | $73,739,596 | |
| 5 | ALMR |
Alamar Biosciences, Inc.
|
2,202,597 | $59,668,352 | |
| 6 | QDEL |
QuidelOrtho Corp
|
1,743,563 | $30,547,223 | |
| 7 | IRMD |
Iradimed Corp
|
318,680 | $30,453,060 | |
| 8 | STE |
STERIS plc
|
118,752 | $25,005,608 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,385,402 | 35,418 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $206,800 | 3,293 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $178,336 | 2,687 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $144,606 | 2,149 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,211 | 243 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||